Gynuity Health Projects: Postpartum Hemorrhage trials

The registry lists 23 Postpartum Hemorrhage studies with Gynuity Health Projects as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 3 2Phase 4 4No phase 17(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Association Between Shock Index and Severity of Postpartum Blood LossCompletedNCT03135158
• IV Versus IM Administration of Oxytocin for Postpartum BleedingCompletedNCT02954068Phase 4
• Introduction of UBT for PPH Management in Three CountriesCompletedNCT02910310Not applicable
• Misoprostol as First Aid Measure to Address Excessive Postpartum BleedingStatus unknownNCT02853552Phase 4
• Effectiveness of Tranexamic Acid When Used as an Adjunct to Misoprostol for the Treatment of Postpartum HemorrhageCompletedNCT02805426Phase 4
• Comparison of Primary and Secondary Prevention of Postpartum Hemorrhage at the Community Level in EgyptCompletedNCT02226588Phase 4
• Treatment of Postpartum Hemorrhage With Misoprostol: Fever StudyCompletedNCT02163616Phase 3
• Oxytocin Via Intramuscular Injection and Intravenous Bolus or Infusion for Prevention of Postpartum HemorrhageCompletedNCT01914419Not applicable
• Excellent BRASSS-V Drape™ Versus Indirect Measurement Protocol for Measurement of Postpartum Blood LossCompletedNCT01885845Not applicable
• Comparing Misoprostol and Oxytocin in Uniject for Postpartum Hemorrhage (PPH) Prevention in SenegalCompletedNCT01713153Not applicable
• Misoprostol and Oxytocin in Uniject® for Postpartum Hemorrhage Prevention in CommunitiesWithdrawnNCT01710566Phase 3
• Misoprostol for Treatment of Postpartum Hemorrhage at Community-level Births in EgyptCompletedNCT01619072Not applicable
• IV vs IM Oxytocin in the Third Stage of Labor for Prevention of Postpartum HemorrhageCompletedNCT01608958Not applicable
• A Study of Self-administered Misoprostol to Prevent Bleeding After Childbirth in the Community (MamaMiso)CompletedNCT01510574Not applicable
• Misoprostol for Treatment of Postpartum Haemorrhage (PPH) in Home BirthsCompletedNCT01508429Not applicable
• Comparing Misoprostol and Oxytocin in UnijectTM for Postpartum Hemorrhage (PPH) Prevention in MaliWithdrawnNCT01487278Not applicable
• Treatment of Postpartum Haemorrhage (PPH) Using Misoprostol in Home BirthsCompletedNCT01485562Not applicable
• Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in IndiaCompletedNCT01462422Not applicable
• Fever After Misoprostol Administration for the Treatment of Primary Postpartum HemorrhageCompletedNCT01080846Not applicable
• Misoprostol for Preventing Postpartum HemorrhageCompletedNCT00124540Not applicable
• Misoprostol for the Prevention of Postpartum Hemorrhage in Rural PakistanCompletedNCT00120237Not applicable
• Misoprostol in the Treatment of Postpartum HemorrhageCompletedNCT00116480Not applicable
• Misoprostol for the Treatment of Postpartum HemorrhageCompletedNCT00116350Not applicable